Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug registration

E4 Dose-Response Information to Support Drug Registration Ethnic Factors... [Pg.80]

Please refer to the Drug Registration and Listing Instruction Booklet.)... [Pg.244]

For pharmaceutical products, the synthesis route is usually established very early on because of drug registration procedures carried out with governmental agencies, e.g. the Food and Drug Administration (FDA). [Pg.196]

Development of harmonized requirements for world drug registrations would be of considerable benefit to pharmaceutical companies and to patients, for whom many drugs would be available much more quickly. [Pg.101]

Keywords Orphan drugs registration and usage of pharmaceutical products vaccines and antibiotics in biological prevention... [Pg.133]

Yakuji Nippo, Ltd. (1991). Drug Registration Requirements in Japan. Yakuji Nippo, Ltd., Tokyo, Japan. [Pg.98]

Are there conditions under which such a retrospective study would be acceptable for drug registration ... [Pg.214]

Exhibit 7.5 Division of Pharmaceuticals, Division of Biological Products, and Office for Acceptance of Drug Registration... [Pg.218]

An application on the prescribed form is submitted to the Department of Drug Registration (DDR) of the State Food and Drug Administration (SFDA). The DDR evaluates the completeness of the document and then forwards it to the Center for Drug Evaluation (CDE) for technical review. External experts may be consulted, and the CDE compiles a technical report for the DDR. [Pg.264]

Committee for Veterinary Medicinal Products (EMEA) Department of Drug Registration (China)... [Pg.437]

The ICH-EWG-Q produced two guidelines, Q6A and Q6B, dealing with specifications to support a new drug registration. Biotechnology-related specifications are treated by Q6B, and all others previously subject to EWG-Q guidelines are treated by Q6A. Pharmacopeial methods are intrinsic to these guidelines. [Pg.87]

The European Agency for the Evaluation of Medicinal Producte. ICH Tripartite Guideline. Dose-response Information to Support Drug Registration. London EMEA, 1994. [Pg.174]


See other pages where Drug registration is mentioned: [Pg.322]    [Pg.327]    [Pg.332]    [Pg.338]    [Pg.169]    [Pg.243]    [Pg.573]    [Pg.584]    [Pg.43]    [Pg.87]    [Pg.106]    [Pg.122]    [Pg.1074]    [Pg.331]    [Pg.336]    [Pg.341]    [Pg.347]    [Pg.97]    [Pg.100]    [Pg.7]    [Pg.76]    [Pg.83]    [Pg.216]    [Pg.217]    [Pg.219]    [Pg.228]    [Pg.422]    [Pg.656]    [Pg.85]    [Pg.88]   
See also in sourсe #XX -- [ Pg.65 , Pg.107 ]




SEARCH



Drug registration dose-response information

Drug registration ethnic issues

Drug registration future

Drug registration in Japan

Drug registration medical practice

Drug registration, stability studies

Drug registration, stability studies support

Drug regulation registration

Drug, molecular registration systems and

Ethnic issues in drug registration

Japan, drug registration

National drug policies registration

Registration

Registration system, drug

United drug producer registration

© 2024 chempedia.info